Tempus AI is trading at $71.51, up +4.67%, with no clearly reported company-specific catalyst for the October 15 gain.
- The highlighted Moderna/Merck collaboration predates the session.
- Inflation and interest-rate concerns weighed on technology and AI-related shares before U.S. stocks rebounded; Reuters reported that higher-rate fears could make AI investments harder to finance.
- The gain ran counter to the software-sector decline, and available evidence does not establish a specific cause.